Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 366-372

  Touyz, Rhian M ^a   Endemann, Dierk ^a   He, Gang ^a   Li, Jin S ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Arteries; Hypertension; Losartan; PD123319; Receptors, angiotensin; Resistance; Vasoconstriction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BINDING AFFINITY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HYPERTENSION; MEDIATOR RELEASE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; VASCULAR SMOOTH MUSCLE; AGING; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; IN VITRO STUDY; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; SUPERIOR MESENTERIC ARTERY; VASOCONSTRICTION; WISTAR KYOTO RAT;

AGING; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; HYPERTENSION; IMIDAZOLES; LOSARTAN; MESENTERIC ARTERY, SUPERIOR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PYRIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTION;

EID: 0032608801     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.366     Document Type: Article

References (46)

1. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 1992;19(suppl II):II-62-II-67.
2. Wolf G, Zihadeb FN, Zahner G, Stahl RAK. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension. 1996;21: 897-905.
3. Itoh H, Muloyama M, Prall RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2272.
4. Scott-Burden T, Resink TJ, Hahn AWA, Buhler FR. Angiotensin-induced growth related metabolism is activated in cultured smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Am J Hypertens. 1991;4:183-188.
5. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Dunica JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;165:196-203.
6. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 25:205-251.
7. Inagami T. Recent progress in molecular and cell biological studies of angiotensin receptors. Curr Opin Nephrol Hypertens. 1995;4:47-54.
8. Viswanathan M, Tsutsumi K, Correa FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
9. Viswanathan M, Saavedra JM. Angiotensin II receptor subtypes and growth. In: JM Saavedra, PBMWM Timmermans, eds. Angiotensin Receptors. New York, NT: Plenum Press; 1994:205-218.
10. Chatziantoniou C, Arendshorst WJ. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol 1993; 265:F853-F862.
11. Touyz RM, Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction and growth via tyrosine kinase-dependent signaling pathways. Hypertension. 1997;30(part 1):222-229.
12. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
13. 10 vascular smooth muscle cells. J Mol Cell Cardiol. 1996;28:499-506.
14. 2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure J Clin Invest. 1996;98:418-425.
15. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury Hypertension 1992;20:737-745.
16. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes. 1994;43:1180-1184.
17. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Indana M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
18. Wiemer G, Scholkens BA, Wagner A, Heitsch H, Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens. 1993;11(suppl 5):234-235.
19. Wu JN, Edwards D, Berecek KH. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril. Hypertension. 1994; 23:819-822.
20. Bohr DF, Dominiczak AF, Webb RC. Pathophysiology of the vasculature in hypertension. Hypertension. 1991;18(suppl III):III-69-III-75.
21. Bodin P, Travo C, Stoclet JC, Travo P. High sensitivity of hypertensive aortic myocytes to norepinephrine and angiotensin. Am J Physiol. 1993; 264:C441-C445.
22. Sitzmann JV, Li SS, Wu YP, Groszmann R, Bulkley GB. Decreased mesenteric vascular response to angiotensin II in portal hypertension. J Surg Res. 1990;48:341-344.
23. Resink TJ, Scott-Burden T, Baur U, Burgin M, Buhler FR. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension. 1989;14:293-303.
24. Touyz RM, Tolloczko B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1. J Hypertens. 1994;12:663-673.
25. Berecek KH, Scwertschlag U, Gross F. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am J Physiol. 1980;238:H287-H293.
26. Chatziantoniou C, Daniels FH, Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol. 1990;259:F372-F382.
27. Falloon BJ, Heagerty AM. In vitro perfusion studies on human resistance artery function in essential hypertension. Hypertension. 1994;24:16-23.
28. Touyz RM, Deng LY, Li JS, Schiffrin EL. Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats. J Hypertens. 1996;14:983-991.
29. Falloon BJ, Stephens N, Tulip JR, Heagerty AM. Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol. 1995;268(2, pt 2):H670-H678.
30. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term Hypertension. 1990;16:603-614.
31. Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in SHR. Hypertension. 1984;6:682-688.
32. 2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats. Regul Pept. 1994;52:21-29.
33. Hayashi K, Suzuki H, Saruta T. Segmental differences in angiotensin receptor subtypes in interlobular artery of hydronephrotic rat kidneys. Am J Physiol. 1993;265:F881-F885.
34. Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, de Gasparo M. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun. 1992;183:206-211.
35. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol. 1993;264:R917-R923.
36. Endo Y, Arima S, Yaoita H, Omata K, Tsunoda K, Takeuchi K, Abe K, Ito S. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int. 1997;63:S205-S207.
37. Kambayashi Y, Bardhan S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;194:478-482.
38. Tsuzuki S, Eguchi S, Inagami T. Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem Biophys Res Commun. 1996; 228:825-830.
39. Sabri A, Levy BI, Poitevin P, Caputo L, Faggin E, Marotte F, Rappaport L, Samuel JL. Differential roles of ATI and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol. 1997;17:257-264.
40. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs for angiotensin II type 1 and 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension. 1998;32: 467-472.
41. Sadoshima J. Versatility of the angiotensin II type 1 receptor Circ Res. 1998;82:1352-1355.
42. Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol. 1997;59:395-412.
43. 2) receptor protein in rat heart. Hypertension. 1998;32:78-83.
44. Nio Y, Matsubara H, Murasawa S, Kanasaski M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
45. 2) receptor antagonizes the growth effects of the AT1 receptor: gain-of function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92: 10663-10667.
46. 2 receptors in the rat skin during experimental wound healing. Peptides. 1992;13: 783-786.